MENU

Focal Therapy2026 PR Video

  • 第113回日本泌尿器科学会総会

Program

(April 16, 2026 update)

icon

Keynote Lecture

April 26 Sun. 11:45-12:00 / Room1(1F/RoomC-1)

Focal Therapy as a Field: The Future of Focal Therapy for Prostate Cancer

Speaker
Andre AbreuUniversity of Southern California, USA
Andre Abreu

25th April.

icon

Session 1

April 25 Sat. 8:10-9:25 / Room1(1F/RoomC-1)

Imaging

Moderator
Eduard BacoOslo University Hospital, Norway
Tsuyoshi IwataKyoto Min-iren Chuo Hospital, Japan
S1-1Biparametric MRI should be a new standard of care for prostate cancer diagnosis: results from the PRIME trial
Speaker
Veeru KasivisvanathanUniversity College London and University of Vienna, United Kingdom
S1-2MRI interpretation for selection and follow up after Focal Therapy for PCa
Speaker
Andrei S. PuryskoCleveland Clinic, USA
S1-3PSMA-PET for patient selection and follow up for Focal Therapy for Prostate Cancer
Speaker
Andrei S. PuryskoCleveland Clinic, USA
S1-4Multiparametric Ultrasound for selection, intra-operative evaluation and follow up after focal therapy for Pca
Speaker
Osamu UkimuraKyoto Prefectrual University of Medicine, Japan
S1-5Salvage Localized Options for Radiorecurrent Prostate Cancer
Speaker
Tarik BenidirUniversity of Florida, USA
icon

Session 2

April 25 Sat. 8:30-9:45 / Room2(1F/RoomC-2)

Patient Selection

Moderator
Ardeshir RastinehadNorthwell Health, USA
Sunao ShojiTokai University School of Medicine, Japan
S2-1Patient Selection and the Ideal Candidate for Focal Therapy in Prostate Cancer
Speaker
Andre AbreuUniversity of Southern California, USA
S2-2Pushing the Limits of Focal Therapy: How Much Pattern 4 Is Acceptable?
Speaker
Ardeshir RastinehadNorthwell Health, USA
S2-3Do genomic biomarkers have a role in patient selection for Focal Therapy?
Speaker
Bruno NaharUniversity of Miami, USA
S2-4Contemporary Patient Selection for Focal Therapy in Localized Prostate Cancer: A Risk-Adapted, Biologically Informed Framework
Speaker
Ardalan AhmadUniversity of Manitoba, Canada
S2-5FLAME-PC: Focal or radical therapy: a Lesion-based Molecular Evaluation in Prostate Cancer
Speaker
Kae Jack TaySingapore General Hospital, Singapore
icon

Session 3

April 25 Sat. 10:30-11:00 / Room2(1F/RoomC-2)

Artificial Intelligence

Moderator
Andre AbreuUniversity of Southern California, USA
Masatomo KanekoKyoto Prefectural University of Medicine, Japan
S3-1Artificial Intelligence and MRI in Focal Therapy for Prostate Cancer: Patient Selection, Intraoperative Guidance, and Follow-up
Speaker
Masatomo KanekoKyoto Prefectural University of Medicine, Japan
S3-2Targeted Microwaves Ablation TMA, a new Focal Therapy for localized Prostate Cancer: from in vivo experimentation to clinical application.
Speaker
Alexandre PeltierJules Bordet Institute, Belgium
icon

Session 4

April 25 Sat. 13:15-15:00 / Room1(1F/RoomC-1)

Focal Therapy Outcomes

Moderator
Peter Ka-Fung ChiuThe Chinese University of Hong Kong, Hong Kong
Kae Jack TaySingapore General Hospital, Singapore
S4-1MRI-based management of FT for PCa
Speaker
Sunao ShojiTokai University School of Medicine, Japan
S4-2Outcomes of prostate cancer focal therapy in Asia a multi-institutional and multi-modality study
Speaker
Peter Ka-Fung ChiuThe Chinese University of Hong Kong, Hong Kong
S4-3Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal): Study Protocol and Interim Results
Speaker
Kae Jack TaySingapore General Hospital, Singapore
S4-4Follow up, Regular convalescence, complications and regrets after FT for Pca
Speaker
James WysockNYU School of Medicine, USA
S4-5Efficacy and Outcomes after Focal Therapy: A Historical perspective and impact on clinical trial design
Speaker
Kara WattsMontefiore Medical Center, USA
S4-6Clinical Evidence Supporting Focal Therapy for Prostate Cancer : Impacts on guidelines
Speaker
Munehiro OhashiKyoto Tanabe Central Hospital, Japan
S4-7Back to the future, subtotal ablation should be the standard: balancing QoL vs optimal PCa control
Speaker
Inderbir GillUniversity of Southern California, USA
icon

Session 5

April 25 Sat. 14:15-16:30 / Room2(1F/RoomC-2)

Improving Focal Therapy Outcomes

Moderator
Thomas PolascikDuke Cancer Institute, USA
Sunao ShojiTokai University School of Medicine, Japan
S5-1Focal HIFU for Prostate Cancer: Lesion Volume Correlated to Biopsy Result Post Treatment
Speaker
Cary N RobertsonDuke University Medical Center, USA
S5-2Come with less, expect more? Baseline sexual function as a critical lens for interpreting whole-gland vs partial-gland cryoablation outcomes: insights from 20+ years of experience
Speaker
Thomas PolascikDuke Cancer Institute, USA
S5-3Contrast enhanced ultrasound use in focal therapy
Speaker
Tarik Benidir University of Florida, USA
S5-4The Apex: how to handle apical lesions with Focal Ablation; Technical and Procedural considerations. Anatomy Matters: Location Dictates Energy Selection for Partial Prostate Gland Ablation.
Speaker
Jonathan Samuel FainbergMemorial Sloan Kettering Cancer Center, USA
S5-5Prostate Compression for HIFU
Speaker
Sunao ShojiTokai University School of Medicine, Japan
S5-6Natural History of Patients Undergoing Transperineal Fusion Cryoablation in the Office Setting: Intermediate Term Outcomes
Speaker
Fernando J. BiancoNOVA SouthEastern University, USA
icon

Session 6

April 25 Sat. 15:15-16:00 / Room1(1F/RoomC-1)

Guidance

Moderator
Atsuko FujiharaKyoto Prefectural University of Medicine, Japan
Toshitaka ShinOita University Faculty of Medicine, Japan
S6-13D navigation for focal therapy for Pca
Speaker
Atsuko FujiharaKyoto Prefectural University of Medicine, Japan
S6-2Telesurgery in Focal Therapy
Speaker
Ruben Olivares GribbellCleveland Clinic, USA
S6-3Robotic MRI/US fusion Guided Irreversible Electroporation in Intermediate Risk Prostate Cancer utilizing the Biobot Mona Lisa 2.0 Platform
Speaker
Srinivas VourgantiRush University Medical Center, USA

26th April.

icon

Session 7

April 26 Sun. 7:30-9:30 / Room1(1F/RoomC-1)

Clinical Trials

Moderator
Inderbir GillUniversity of Southern California, USA
Atsuko FujiharaKyoto Prefectural University of Medicine, Japan
S7-1Critical apraisai of current clinical trials in FT for Pca
Speaker
Soroush Rais-BahramiWake Forest University School of Medicine, USA
S7-2HIFI-HIFU vs RALP
Speaker
Sébastien CrouzetUniversity Claude Bernard LYON 1, France
S7-3Water Ⅳ- Aquablation vs RALP
Speaker
Inderbir GillUniversity of Southern California, USA
S7-4The Captain Trial: TULSA vs RP
Speaker
Laurence KlotzUniversity of Toronto, Canada
S7-5Latest Update on the Oncological Results of the RCT Comparing Focal Ablation versus Robotic Prostatectomy in Patients with Unilateral Clinically Significant Prostate Cancer
Speaker
Eduard BacoOslo University Hospital, Norway
S7-6Cryoablation in metastatic prostate cancer: a scoping review
Speaker
Thomas PolascikDuke Cancer Institute, USA
S7-7IRE(PRESERVE)- Singke Arm IRE
Speaker
Derek LomasMayo Clinic, USA
S7-8PFLT-PC trial: pivotal trial results for 100 men using Profocal Laser ablation system
Speaker
Isaac ThangasamyUniversity of Sydney, Australia
S7-9Targeted Microwave Ablation of Localized Prostate Cancer (VIOLETTE) : A Prospective, Multicentre Study
Speaker
Julien AnractParis Cite University, France
icon

Session 8

April 26 Sun. 8:45-10:00 / Room2(1F/RoomC-2)

Tumor Board1

Moderator
Sébastien CrouzetUniversity Claude Bernard LYON 1, France
Andre AbreuUniversity of Southern California, USA
S8-1HIFU
Speaker
Sunao ShojiTokai University School of Medicine, Japan
S8-2HIFU
Speaker
Sébastien CrouzetUniversity Claude Bernard LYON 1, France
S8-3IRE
Speaker
Jonathan Samuel FainbergMemorial Sloan Kettering Cancer Center, USA
S8-4CRYO
Speaker
Osamu UkimuraKyoto Prefectural University of Medicine, Japan
S8-5Aquablation
Speaker
Mihir DesaiUniversity of Southern California, USA
icon

Session 9

April 26 Sun. 10:15-11:30 / Room1(1F/RoomC-1)

Tumor Board2

Moderator
Yoh MatsuokaSaitama Cancer Center, Japan
Eduard BacoOslo University Hospital, Norway
S9-1 Clinical Outcomes of Focal Low-Dose-Rate Brachytherapy for Localized Prostate Cancer
Speaker
Yoh MatsuokaSaitama Cancer Center, Japan
S9-2Apical disease: how Profocal laser ablation overcomes many of the anatomical limitations of other focal therapies and clinical outcomes
Speaker
Issac ThangasamyUniversity of Sydney, Australia
S9-3TULSA
Speaker
Eduard BacoOslo University Hospital, Fench and Norway
S9-4Targeted Microwave Ablations: a global approach of focal therapy for localized prostate cancer
Speaker
Julien AnractParis Cite University, France
S9-5Partial Prostatectmomy
Speaker
Ruben Olivaras GribbellCleveland Clinic, USA

Industry Sponsored Sessions

DAY 1 Saturday, 25April 2026

9:45-10:15 Sponsored Seminar

Room2: RoomC-2

Latest Advances and Techniques in Robotic Focal Therapy
Speaker
Andre Abreu, MDUniversity of Southern California, USA
Pr. Sebastien CrouzetUniversity Claude Bernard LYON 1, France
James Wysock, MDNYU School of Medicine, USA
(Sponsored by Focal One)

10:30-11:30 Sponsored Seminar

Room1: RoomC-1

Prostate Cancer: Diagnosis and Treatment
Moderator
Yasuhisa FujiiDepartment of Urology, Institute of Science Tokyo
Seminar I Lesion Targeted Focal Therapy for Localized Prostate Cancer with Cryotherapy and Microwave Ablation
Speaker
Atsuko FujiharaDepartment of Urology, Kyoto Prefectural University of Medicine
Seminar II Shared Decision Making in Treatment of Metastatic Prostate Cancer
Speaker
Shusuke AkamatsuDepartment of Urology, Nagoya University Graduate School of Medicine
(Sponsored by Takeda Pharmaceutical Company Limited)

10:30-12:00 Hands-on Technology Seminar

Room3: Banquet Hall Swan

Precision Pathway in Prostate Cancer: From Targeted Biopsy to Focal Therapy with IRE using Biobots Mona Lisa
Speaker
Dr. Srinivas VourgantiDepartment of Urology, Rush University Medical Center
(Sponsored by Biobot Surgical Pte Ltd.)
  • 第113回日本泌尿器科学会総会